INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,140,241 | -18.7% | 1,788,064 | -1.1% | 0.05% | -13.0% |
| Q2 2023 | $114,497,066 | +18.0% | 1,808,229 | +0.9% | 0.05% | +10.2% |
| Q1 2023 | $97,047,039 | +2.3% | 1,792,189 | -0.1% | 0.05% | 0.0% |
| Q4 2022 | $94,909,691 | +13.5% | 1,793,456 | -0.2% | 0.05% | +6.5% |
| Q3 2022 | $83,633,000 | -13.8% | 1,797,410 | +5.7% | 0.05% | -4.2% |
| Q2 2022 | $97,020,000 | -6.7% | 1,699,730 | +0.1% | 0.05% | +14.3% |
| Q1 2022 | $103,943,000 | +82.8% | 1,698,696 | +56.3% | 0.04% | +100.0% |
| Q4 2021 | $56,877,000 | +11.8% | 1,086,682 | -20.4% | 0.02% | +10.5% |
| Q3 2021 | $50,875,000 | -8.7% | 1,364,659 | +0.0% | 0.02% | -9.5% |
| Q2 2021 | $55,705,000 | +40.5% | 1,364,652 | +16.8% | 0.02% | +31.2% |
| Q1 2021 | $39,648,000 | +396.9% | 1,168,546 | +90.1% | 0.02% | +300.0% |
| Q2 2019 | $7,979,000 | +6.6% | 614,700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $7,487,000 | +6.9% | 614,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $7,001,000 | -34.6% | 614,700 | +24.7% | 0.00% | -20.0% |
| Q3 2018 | $10,700,000 | +9.0% | 493,100 | +94.9% | 0.01% | 0.0% |
| Q2 2016 | $9,821,000 | +39.6% | 253,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $7,033,000 | -71.1% | 253,000 | -44.0% | 0.00% | -66.7% |
| Q4 2015 | $24,308,000 | +29.9% | 451,900 | -3.3% | 0.01% | +33.3% |
| Q3 2015 | $18,719,000 | +59.8% | 467,500 | +27.5% | 0.01% | +80.0% |
| Q2 2015 | $11,716,000 | +33.8% | 366,700 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $8,757,000 | -0.6% | 366,700 | -26.5% | 0.00% | 0.0% |
| Q4 2014 | $8,806,000 | +14.7% | 498,900 | -10.9% | 0.00% | 0.0% |
| Q3 2014 | $7,675,000 | -45.0% | 559,800 | -32.4% | 0.00% | -33.3% |
| Q2 2014 | $13,962,000 | -8.6% | 828,100 | -1.5% | 0.01% | -14.3% |
| Q1 2014 | $15,277,000 | – | 840,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |